News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

AGENUS OFFERS AN INVESTMENT OPPORTUNITY.

  Saturday, September 07, 2013

 More...


Recent Postings


Archive


Tags

SERES THERAPEUTICS (MCRB) Rapamune Global Cell Therapeutics (GBT) ARGOS (ARGS) Human Longevity (HLI) IDERA (IDRA) Spike Therapeutics (ONCE) Inovio (INO) Seattle Genetics (SGEN) CompuGen (CGEN) Intrexon (XON) Prosensa (RNA) TOKAI (TKAOI) Agenus (AGEN) NANTKWEST (NK) OSI (OSIP) Bristol-Myers Squibb (BMY) Vitae Pharmaceuticals (VTAE) Cytokinetics (CYTK) PTC Therapeutics (PTCT) Micromet (MITI) Alnylam (ALNY) Xoma (XOMA) AGOS (ARGS) Telaprevir REGULUS (RGLS) Intercept (ICPT) Roche (ROCHE) Ridaforolimus Dendreon (DNDN) Amgen (AMGN) Jazz Pharmaceuticals (JAZZ) Sarepta (SRPT) Roche (RHHBY) NEKTAR (NKTR)) Velcade (bortezomib) Anacor (ANAC) galapagos (GLPG) GUARDIAN HEALTH Herceptin Editas (EDIT) Prolor Biotech (PBTH) Agenus (AGEN ZALTRAP™ Abbott Laboratories (ABT) SUNESIS PHARMACEUTICALS (SNSS) Galena (GALE) SYNTA (SNTA) Onyx (ONXX) GlaxoSmithKline (GSK) Anadys (ANDS) Array Pharmaceuticals (ARRY) ARCA (ABIO) Ziofpharm (ZIOP) Tysabri Regeneron (REGN) Sanofi (SNY) C4 Therapeutics Auspex (ASPX) AERIE PHARMACEUTICALS Alder Biopharmaceuticals (ALDR) Valeant Pharmaceuticals International (VRX) Illumina (ILMN) Exelixis (EXEL) Dynavax (DVAX) Human Genome Sciences (HGSI) ADVENTRIX (ANX) Pluristem (PSTI) Sanofi (SNA) BIOMARIN (BMRN) Sangamo (SGMO) ImmunoGen (IMGN) Elan (ELN) ABBVIE (ABBV) INNOVIVA (INVA) Theravance Bio Pharma (TBPH) Zerenex KITE (KITE) Mirati Therapeutics (MRTX) Idenix (IDIX) ACADIA (ACAD) Vertex (VRTX) Benlysta (belimumab) Merck (MRK) Incyte (INCY) Sequenom (SQNM) Endometrial Cancer ISIS (ISIS) Revlimid (lenolidamide) Trastuzumab-DM1 Aimmune Therapeutics (AIMT) Gilead (GILD) JUNO (JUNO) Sanofi-Aventis (SAN) Ionis (IONS) HALOZYME (HALO) Biocryst (BCRX) Genentech Ariad (ARIA) Multiple Myeloma Biogen Idec (BIIB) Intermune (ITMN) RenenxBio (RGNX) Theravance (THRX) KERYX (KERX) VANDA (VNDA)